<DOC>
	<DOCNO>NCT02073058</DOCNO>
	<brief_summary>The purpose study demonstrate point accuracy Abbott Sensor Based Glucose Monitoring ( GM ) System interstitial glucose result Reader capillary Blood Glucose ( BG ) reference use Consensus Error Grid . During course wear duration , subject require test fingerstick glucose measurement least eight ( 8 ) time day capillary reference glucose measurement three in-clinic visit maximum 13 hour venous reference glucose measurement . With every reference measurement , subject study staff perform measurement System .</brief_summary>
	<brief_title>Evaluation Accuracy Abbott Sensor Based Interstitial Glucose Monitoring System</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Subject must least 18 year age . 2 . Subject must type 1 type 2 diabetes least 2 year prior enrollment . 3 . Subject must require insulin therapy insulin pump and/or multiple daily insulin injection ( least 3 injection daily ) least 6 month prior enrollment . 4 . Subject must able read understand English . 5 . In investigator 's opinion , subject must able follow instruction provide him/her study site perform study task specify protocol . 6 . Subject must available participate study visit . 7 . Subject must willing able provide write sign date informed consent . 1 . Subject know allergy medical grade adhesive isopropyl alcohol use disinfect skin . 2 . Subject pregnant , attempt conceive willing able practice birth control study duration ( applicable female subject ) . 3 . Subject skin lesion , scar , redness , infection edema application site could interfere device placement accuracy interstitial glucose measurement . 4 . Subject currently participate another clinical trial . 5 . Subject donate blood within 112 day ( 3.7 month ) prior begin study activity . 6 . Subject concomitant medical condition , opinion investigator , could interfere study present risk safety welfare subject study staff . Such condition include limited : â€¢ History HIV , Hepatitis B C 7 . Subject know medical condition , opinion investigator , may increase risk bleed . 8 . Subject Xray , MRI CT appointment schedule period study participation , appointment reschedule time study participation start study participation end . 9 . Subject unsuitable participation due cause determine Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Subjects Type 1 Type 2 Diabetes Requiring Multiple daily Insulin Injection ( MDI ) Continuous Subcutaneous Insulin Infusion ( CSII )</keyword>
</DOC>